TY - JOUR
T1 - Uhthoff's phenomena in MS - Clinical features and pathophysiology
AU - Frohman, Teresa C.
AU - Davis, Scott L.
AU - Beh, Shin C
AU - Greenberg, Benjamin
AU - Remington, Gina
AU - Frohman, Elliot
N1 - Funding Information:
The authors thank Kimberly Hoggatt for her preparation of the artwork contained within Figures 1 and 4. The authors have received research funding from the National Multiple Sclerosis Society (grants RG 3780A3/3 and PP1485 to E. M. Frohman; RG 4091A3/1 to Robert Fox at Cleveland Clinic and subcontracted to E. M. Frohman; RG 4212-A-4 to Laura J. Balcer at New York University and subcontracted to E. M. Frohman; RG 4043A1/1 to S. L. Davis) and the National Eye Institute (grants R01 EY 014993 and R01 EY 019473 to Laura J. Balcer subcontracted to E. M. Frohman). E. M. Frohman has also received funding from Dale Energy Corporation, the Braxton Debbie Angela Dillon and Skip (DADS) Donor Advisor Fund, and the Cain Denius MS Research Fund. Written consent for publication of the case report was obtained from the family of the patient.
PY - 2013/9
Y1 - 2013/9
N2 - In the late 19th century, Wilhelm Uhthoff reported on a series of patients with acute optic neuritis who manifested similar recurrent, stereotyped visual symptoms that were of paroxysmal onset, short in duration, and reversible. These 'Uhthoff's phenomena', which are a feature of multiple sclerosis (MS) and other demyelinating diseases, can be triggered by factors including the perimenstrual period, exercise, infection, fever, exposure to high ambient temperatures, and psychological stress. Here, we characterize the clinical, pathophysiological and neurotherapeutic challenges associated with Uhthoff's phenomena, and discuss the differentiation of these events from other paroxysmal, acute or subacute changes in functional capabilities and neurological symptoms in MS. For instance, whereas MS exacerbations are contingent on immune dysregulation, Uhthoff's phenomena are predicated on ion channel modifications, in conjunction with thermoregulatory derangements that transiently alter the conduction properties of demyelinated axons. An understanding of these pathophysiological underpinnings of Uhthoff's phenomena is germane to their recognition and timely treatment.
AB - In the late 19th century, Wilhelm Uhthoff reported on a series of patients with acute optic neuritis who manifested similar recurrent, stereotyped visual symptoms that were of paroxysmal onset, short in duration, and reversible. These 'Uhthoff's phenomena', which are a feature of multiple sclerosis (MS) and other demyelinating diseases, can be triggered by factors including the perimenstrual period, exercise, infection, fever, exposure to high ambient temperatures, and psychological stress. Here, we characterize the clinical, pathophysiological and neurotherapeutic challenges associated with Uhthoff's phenomena, and discuss the differentiation of these events from other paroxysmal, acute or subacute changes in functional capabilities and neurological symptoms in MS. For instance, whereas MS exacerbations are contingent on immune dysregulation, Uhthoff's phenomena are predicated on ion channel modifications, in conjunction with thermoregulatory derangements that transiently alter the conduction properties of demyelinated axons. An understanding of these pathophysiological underpinnings of Uhthoff's phenomena is germane to their recognition and timely treatment.
UR - http://www.scopus.com/inward/record.url?scp=84883743102&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883743102&partnerID=8YFLogxK
U2 - 10.1038/nrneurol.2013.98
DO - 10.1038/nrneurol.2013.98
M3 - Review article
C2 - 23732530
AN - SCOPUS:84883743102
SN - 1759-4758
VL - 9
SP - 535
EP - 540
JO - Nature Reviews Neurology
JF - Nature Reviews Neurology
IS - 9
ER -